185 related articles for article (PubMed ID: 31281982)
41. The level of fatty acid-binding protein 4, a novel adipokine, is increased in rheumatoid arthritis and correlates with serum cholesterol levels.
Andrés Cerezo L; Kuklová M; Hulejová H; Vernerová Z; Pešáková V; Pecha O; Veigl D; Haluzík M; Pavelka K; Vencovský J; Senolt L
Cytokine; 2013 Oct; 64(1):441-7. PubMed ID: 23714112
[TBL] [Abstract][Full Text] [Related]
42. NAPSI utilization as an evaluation method of nail psoriasis in patients using acitretin.
Mukai MM; Poffo IF; Werner B; Brenner FM; Lima Filho JH
An Bras Dermatol; 2012; 87(2):256-62. PubMed ID: 22570030
[TBL] [Abstract][Full Text] [Related]
43. Methotrexate Decreases the Level of PCSK9-A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data.
Krahel JA; Baran A; Kamiński TW; Maciaszek M; Flisiak I
J Clin Med; 2020 Mar; 9(4):. PubMed ID: 32225075
[TBL] [Abstract][Full Text] [Related]
44. Efficacy and safety of total glucosides of paeony combined with acitretin in the treatment of moderate-to-severe plaque psoriasis: a double-blind, randomised, placebo-controlled trial.
Yu C; Fan X; Li Z; Liu X; Wang G
Eur J Dermatol; 2017 Apr; 27(2):150-154. PubMed ID: 28400341
[TBL] [Abstract][Full Text] [Related]
45. Small molecule inhibitors of human adipocyte fatty acid binding protein (FABP4).
Zhang M; Zhu W; Li Y
Med Chem; 2014 Jun; 10(4):339-47. PubMed ID: 24024500
[TBL] [Abstract][Full Text] [Related]
46. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
[TBL] [Abstract][Full Text] [Related]
47. Effects of retinoid therapy on insulin sensitivity, lipid profile and circulating adipocytokines.
Corbetta S; Angioni R; Cattaneo A; Beck-Peccoz P; Spada A
Eur J Endocrinol; 2006 Jan; 154(1):83-6. PubMed ID: 16381995
[TBL] [Abstract][Full Text] [Related]
48. Circulating Serum Fatty Acid-Binding Protein 4 Levels Predict the Development of Diabetic Retinopathy in Type 2 Diabetic Patients.
Zhang XZ; Tu WJ; Wang H; Zhao Q; Liu Q; Sun L; Yu L
Am J Ophthalmol; 2018 Mar; 187():71-79. PubMed ID: 29305311
[TBL] [Abstract][Full Text] [Related]
49. Fasting serum level of fatty-acid-binding protein 4 positively correlates with metabolic syndrome in patients with coronary artery disease.
Hsu BG; Chen YC; Lee RP; Lee CC; Lee CJ; Wang JH
Circ J; 2010 Feb; 74(2):327-31. PubMed ID: 20009357
[TBL] [Abstract][Full Text] [Related]
50. Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases.
Furuhashi M
J Atheroscler Thromb; 2019 Mar; 26(3):216-232. PubMed ID: 30726793
[TBL] [Abstract][Full Text] [Related]
51. Thalidomide Improves Psoriasis-like Lesions and Inhibits Cutaneous VEGF Expression without Alteration of Microvessel Density in Imiquimod- induced Psoriatic Mouse Model.
Liu JH; Wu HH; Zhao YK; Wang F; Gao Q; Luo DQ
Curr Vasc Pharmacol; 2018; 16(5):510-521. PubMed ID: 28982338
[TBL] [Abstract][Full Text] [Related]
52. Impact of Helicobacter pylori infection on severity of psoriasis and response to treatment.
Onsun N; Arda Ulusal H; Su O; Beycan I; Biyik Ozkaya D; Senocak M
Eur J Dermatol; 2012; 22(1):117-20. PubMed ID: 22063790
[TBL] [Abstract][Full Text] [Related]
53. Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease.
Lamounier-Zepter V; Look C; Alvarez J; Christ T; Ravens U; Schunck WH; Ehrhart-Bornstein M; Bornstein SR; Morano I
Circ Res; 2009 Aug; 105(4):326-34. PubMed ID: 19608978
[TBL] [Abstract][Full Text] [Related]
54. Long-term safety and drug survival of acitretin in psoriasis: a retrospective observational study.
Chularojanamontri L; Silpa-Archa N; Wongpraparut C; Limphoka P
Int J Dermatol; 2019 May; 58(5):593-599. PubMed ID: 30548592
[TBL] [Abstract][Full Text] [Related]
55. Investigating the Role of FABP4 in Diabetes and Obesity and the Influence of Age and Ethnicity: A Comprehensive Analysis of a Cohort from the KEDP-Study.
Abdalla MA; Abubaker J; Abu-Farha M; Al-Khairi I; Cherian P; Qaddoumi MG; Al-Rashed F; Thanaraj TA; Albatineh AN; Al-Mulla F
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731797
[TBL] [Abstract][Full Text] [Related]
56. Higher Serum Selenoprotein P Level as a Novel Inductor of Metabolic Complications in Psoriasis.
Baran A; Nowowiejska J; Krahel JA; Kaminski TW; Maciaszek M; Flisiak I
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32605214
[TBL] [Abstract][Full Text] [Related]
57. Weight loss in prepubertal obese children is associated with a decrease in adipocyte fatty-acid-binding protein without changes in lipocalin-2: a 2-year longitudinal study.
Corripio R; Gónzalez-Clemente JM; Pérez-Sánchez J; Näf S; Gallart L; Nosàs R; Vendrell J; Caixàs A
Eur J Endocrinol; 2010 Dec; 163(6):887-93. PubMed ID: 20870707
[TBL] [Abstract][Full Text] [Related]
58. FABP4 as a biomarker for knee osteoarthritis.
Zhang C; Li T; Chiu KY; Wen C; Xu A; Yan CH
Biomark Med; 2018 Feb; 12(2):107-118. PubMed ID: 29393670
[TBL] [Abstract][Full Text] [Related]
59. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.
Suh JB; Kim SM; Cho GJ; Choi KM
Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697
[TBL] [Abstract][Full Text] [Related]
60. Local Production of Fatty Acid-Binding Protein 4 in Epicardial/Perivascular Fat and Macrophages Is Linked to Coronary Atherosclerosis.
Furuhashi M; Fuseya T; Murata M; Hoshina K; Ishimura S; Mita T; Watanabe Y; Omori A; Matsumoto M; Sugaya T; Oikawa T; Nishida J; Kokubu N; Tanaka M; Moniwa N; Yoshida H; Sawada N; Shimamoto K; Miura T
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):825-34. PubMed ID: 27013610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
